Early Lung Cancer Detection Using Computed Tomography

Lung Cancer Clinical Trial

Official title:

Lung Cancer Screening in High-risk Smokers Using Low-dose Computed Tomography

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00188734
• Other study ID #: I-ELCAP
• Status: Completed
• Phase: N/A
• First received: September 12, 2005
• Last updated: August 9, 2016
• Start date: September 2003
• Est. completion date: June 2016

Study information

• Verified date: August 2016
• Source: University Health Network, Toronto
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Health Canada
• Study type: Observational

Clinical Trial Summary

Early detection of lung cancer may improve treatment outcomes. Risk factors have been identified, suggesting a population which might benefit from regular screening. Lung cancer screening using low-dose computed tomography (LDCT) has experienced a recent renaissance with reported sensitivity for detection of lung cancer of 2.7% in high-risk populations. The purpose of this study is to evaluate the utility of LCDT for the early diagnosis of lung cancer in Ontario.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 5000
• Est. completion date: June 2016
• Est. primary completion date: June 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 55 Years to 85 Years

Eligibility

Inclusion Criteria:

55 years or older at least 10 pack-year history of smoking general good health

Exclusion Criteria:

any prior cancers except non-melanotic skin cancer

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Lung Cancer
• Lung Neoplasms

Locations

Country	Name	City	State
Canada	Princess Margaret Hospital	Toronto	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
University Health Network, Toronto

Country where clinical trial is conducted

Canada, 

External Links

•   Link